Authors: Polk, RE Brophy, DF Israel, DS Patron, R Sadler, BM Chittick, GE Symonds, WT Lou, Y Kristoff, D Stein, DS

Citation: Re. Polk et al., Pharmacokinetic interaction between amprenavir and rifabutin or rifampin in healthy males, ANTIM AG CH, 45(2), 2001, pp. 502-508

Authors: Brophy, DF Israel, DS Pastor, A Gillotin, C Chittick, GE Symonds, WT Lou, Y Sadler, BM Polk, RE

Citation: Df. Brophy et al., Pharmacokinetic interaction between amprenavir and clarithromycin in healthy male volunteers, ANTIM AG CH, 44(4), 2000, pp. 978-984

Authors: Polk, RE Crouch, MA Israel, DS Pastor, A Sadler, BM Chittick, GE Symonds, WT Gouldin, W Lou, Y

Citation: Re. Polk et al., Pharmacokinetic interaction between ketoconazole and amprenavir after single doses in healthy men, PHARMACOTHE, 19(12), 1999, pp. 1378-1384

Authors: Sadler, BM Hanson, CD Chittick, GE Symonds, WT Roskell, NS

Citation: Bm. Sadler et al., Safety and pharmacokinetics of amprenavir (141W94), a human immunodeficiency virus (HIV) type 1 protease inhibitor, following oral administration of single doses to HIV-infected adults, ANTIM AG CH, 43(7), 1999, pp. 1686-1692